Earnings Feed
Start Free
ROCKET PHARMACEUTICALS, INC.·4

Jun 15, 9:07 PM ET

GRANADILLO PEDRO P 4

4 · ROCKET PHARMACEUTICALS, INC. · Filed Jun 15, 2022

Insider Transaction Report

Form 4
Period: 2022-06-13
ROCKET PHARMACEUTICALS, INC.RCKT
GRANADILLO PEDRO P
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-06-13+47,745→ 47,745 total
    Exercise: $10.77Exp: 2032-06-13→ Common Stock (47,745 underlying)
  • Award

    Stock Option (Right to Buy)

    2022-06-13$6.80/sh+10,283$69,924→ 10,283 total
    Exercise: $10.77Exp: 2032-06-13→ Common Stock (10,283 underlying)
Footnotes (2)
  • [F1]This option represents a right to purchase a total of 47,745 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023.
  • [F2]This option represents a right to purchase a total of 10,283 shares of the Issuer's Common Stock, all of which will become fully vested and exercisable on June 13, 2023. This option was issued to the Reporting Person in lieu of director retainer fees of $70,000.

Documents

2 files